https://www.jpost.com/health-and-wellness/article-744695
0
0
5/31/23 at 8:59am
Organization
The Jerusalem Post
Author
By JUDY SIEGEL-ITZKOVICH
40 words
0
Comments
Since anti-PD1 is the leading immunotherapy treatment in cancer patients, such an achievement can impact the quality of life of thousands of cancer patients worldwide every day.
You are the first to view
Create an account
or login to join the discussion